AIMIL Pharma Makes Foray Into Canada For Ayurvedics

New Delhi, Nov 7: | Updated: Nov 8 2003, 05:30am hrs
AIMIL Pharmaceuticals, engaged in the manufacture of ayurvedic medicines and herbal preperations, has set up a manufacturing facility in Canada to manufacture ayurvedic medicines for diabetes, kidney and liver disorders. The company is also setting up another plant at Baddi, Himachal Pradesh at an estimated cost of Rs 10 crore. The plant will have syrup, capsule and granules manufacturing sections along with an exclusive unit for manufacturing chavanprash.

While the Canadian plant will be operational in January 2004, the Baddi facility will commence operations by May 2004. The Canadian plant has been set up in collaboration with a local Canadian partner, where AIMIL has not invested, but will instead provide all the technical know-how and undertake manufacturing. The facility in Canada will give us access to American and European ayurvedic product markets, KK Sharma, chairman, AIMIL, said.

Setting up of the Baddi facility will triple our capacity and will help us double our turnover from Rs 50 crore to Rs 100 crore during the financial year 2004-05, Mr Sharma added.

The new plant in Himachal will be equipped with state-of-the-art technology and is looking at retaining the original ayurvedic concept of processing manufacturing, which would compliment the latest techniques so as to maintain the efficacy and simultaneously result in bulk production in lesser time.

The new plant will also have a quality control laboratory well equiped with the latest chromatographic and spectrophotochromatic techniques to standardise phytoconstituents in raw material, processing and finished products in order to ensure uniformity in the medicines.